BPL MedTech unveils new ICU ventilator BPL Vent 300
The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow
The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow
Day-care model aimed at providing specialized psychological support for women during pregnancy and motherhood
Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region
New platform integrates advanced cardiac mapping and ablation workflow, offering a novel treatment option for AFib patients at risk of stroke and heart failure
A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India
At the center of the project is a new cosmetics line developed through collaboration between industry and medicine
Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) single-dose vials is the bioequivalent to the reference listed drug (RLD) Halaven injection of Eisai, Inc.
The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
Subscribe To Our Newsletter & Stay Updated